Ask a licensed pharmacist directly free, answered by our team
(2025) Disproportionality analysis of GLP-1 receptor agonists combined with metformin based on the FAERS database.Sci Rep 15, 2.Xie Z, Hu J, Gu H, Li M and Chen J (2023) Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.Front
For example, someone with a leaner build might need a shorter needle to ensure the injection is comfortable and delivered correctly
But all that precision is on the line during reconstitution
Moreover, use of dulaglutide in people with T2DM is likely to confer additional renal benefits, and dulaglutide may be used in advanced chronic kidney disease at any eGFR level and without dose adjustment in contrast with most other noninsulin diabetes therapies (134, 135)
The good news is this is entirely preventable